BioCARE: Biomarkers in Cancer Medicine improving Health Care, Education and Innovation
2151 – 2160 of 3090
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2014
-
Mark
The PI3-kinase isoform p110δ is essential for cell transformation induced by the D816V mutant of c-Kit in a lipid-kinase-independent manner.
(
- Contribution to journal › Article
-
Mark
Change in Cell Death Markers During (177)Lu-mAb Radioimmunotherapy-Induced Rejection of Syngeneic Rat Colon Carcinoma.
(
- Contribution to journal › Article
-
Mark
Immune Cell-Poor Melanomas Benefit from PD-1 Blockade after Targeted Type I IFN Activation
(
- Contribution to journal › Article
-
Mark
Low production of reactive oxygen species in granulocytes is associated with organ damage in systemic lupus erythematosus
(
- Contribution to journal › Article
-
Mark
Molecular biology of neuroendocrine tumors: from pathways to biomarkers and targets
(
- Contribution to journal › Scientific review
-
Mark
Use of proton pump inhibitors (PPI) and history of earlier fracture are independent risk factors for fracture in postmenopausal women. The WHILA study.
(
- Contribution to journal › Article
-
Mark
Prediagnostic immunoglobulin E levels and risk of chronic lymphocytic leukemia, other lymphomas and multiple myeloma-results of the European Prospective Investigation into Cancer and Nutrition.
(
- Contribution to journal › Article
-
Mark
Genetic variations associated with the effect of testicular cancer treatment on gonadal hormones.
(
- Contribution to journal › Article
-
Mark
EPO-independent functional EPO receptor in breast cancer enhances estrogen receptor activity and promotes cell proliferation.
(
- Contribution to journal › Article
-
Mark
SYK Is a Critical Regulator of FLT3 in Acute Myeloid Leukemia.
(
- Contribution to journal › Article